Physician profile
Murali Ankem
NPI 1467486498
$2,807.90
in general payments reported to CMS, 2019-2025
28 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $87.21 · 2021: $535 · 2022: $227 · 2023: $384 · 2024: $312 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $929.98 | 2019-2025 | Ams 700, General - Therapies |
| Penumbra, INC. | $177.00 | 2021 | |
| Astellas Pharma US INC | $169.41 | 2019-2023 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $143.39 | 2019-2021 | |
| Photocure INC | $116.49 | 2025 | Cysview |
| Merck Sharp & Dohme LLC | $114.83 | 2019 | |
| Medtronic, INC. | $114.49 | 2024-2025 | Azure Xt Dr Mri Surescan, Interstim |
| Silk Road Medical, INC. | $104.63 | 2021 | |
| Coloplast Corp | $104.57 | 2020-2024 | Porges Coloplast |
| Rochester Medical Corporation | $103.85 | 2019-2022 | |
| Procept Biorobotics Corporation | $103.04 | 2024-2025 | Aquabeam System |
| Olympus America INC. | $97.04 | 2022-2025 | Itind System |
| Karl Storz Endoscopy-America | $69.70 | 2021 | |
| Endo Pharmaceuticals INC. | $57.40 | 2019-2023 | Xiaflex |
| Seagen INC. | $54.24 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $39.90 | 2023-2024 | Botox |
| Amgen INC. | $38.95 | 2019 | |
| Janssen Biotech, INC. | $35.34 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $34.23 | 2019-2021 | |
| Intuitive Surgical, INC. | $32.42 | 2025 | |
| Calyxo, INC. | $29.83 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $28.34 | 2025 | Gemtesa |
| Pfizer INC. | $24.89 | 2019 | |
| Endo USA, INC. | $23.08 | 2024 | Xiaflex |
| Laborie Medical Technologies Corp. | $18.26 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.52 | 2019 | |
| Blue Earth Diagnostics | $15.13 | 2019 | |
| Incyte Corporation | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murali Ankem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.